Found 156 matching trials
Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
PHASE2This phase II trial studies how well dabrafenib, trametinib, and spartalizu...
Location
M D Anderson Cancer Center
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
NAThis study is looking at outcomes in people with advanced cancers who have ...
Location
Peter MacCallum Cancer Centre
Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma
PHASE2Ameloblastoma is the most common benign odontogenic tumor, characterized by...
Location
Multiple Locations
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
PHASE2This research study is studying a combination of drugs as a possible treatm...
Location
Massachusetts General Hosital Cancer Center
Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation
PHASE2This is a single arm phase II trial focused on how dabrafenib and trametini...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma
PHASE2This phase 2 trial will investigate the efficacy and safety of trametinib a...
Location
Universitair Ziekenhuis Brussel
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
NAThis pilot clinical trial studies the feasibility of choosing treatment bas...
Location
Fred Hutch/University of Washington Cancer Consortium
A Clinical Trial of Patients With Melanoma
PHASE1This study is being done to find out if the combination of dabrafenib, tram...
Location
University of Texas Southwestern Medical Center
Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease
PHASE2Erdheim-Chester Diseases (ECD) is a very rare non-Langerhans cell histiocyt...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs
PHASE2This is a prospective non-randomized national clinical phase 2 trial that a...
Location
Turku University Hospital Cancer Centre